Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate in Neutral Lipid Storage Disease With Myopathy
NCT01527318Phase 4Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Aug 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bezafibrate in Neutral lipid storage disease with myopathy (NLSDM), sponsored by Maastricht University Medical Center+. Primary endpoints: Mitochondrial function at 28 weeks, Lipid accumulation at 28 weeks and 1 more. Started Aug 2011; status: completed.
02
Drugs
bezafibrate
03
Conditions
Neutral lipid storage disease with myopathy (NLSDM)
Beyond the preview
Go deeper on NCT01527318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01527318.